D1 Capital Partners L.P. Charles River Laboratories International, Inc. Transaction History
D1 Capital Partners L.P.
- $4.55 Billion
- Q4 2024
A detailed history of D1 Capital Partners L.P. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, D1 Capital Partners L.P. holds 935,820 shares of CRL stock, worth $156 Million. This represents 3.8% of its overall portfolio holdings.
Number of Shares
935,820Holding current value
$156 Million% of portfolio
3.8%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$850 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$364 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$302 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$301 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...